T. Yamanaka

发表

Involvement of tumor necrosis factor-alpha in the pathogenesis of activated macrophage-mediated hepatitis in mice.

J. Nagakawa, I. Hishinuma, K. Hirota, 1990, Gastroenterology.

Involvement of tumor necrosis factor‐α in development of hepatic injury in galactosamine‐sensitized mice

J. Nagakawa, I. Hishinuma, K. Hirota, 1990, Hepatology.

[Effects of E-3123, a new protease inhibitor, on several protease activities and on experimental acute pancreatitis].

J. Nagakawa, I. Hishinuma, K. Miyamoto, 1988, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Suppressive effects of E3330, a novel quinone derivative, on tumor necrosis factor-α generation from monocytes and macrophages

M. Yasuda, J. Nagakawa, I. Hishinuma, 1992, Agents and Actions.

Interleukin-Lα Enhances Hepatotoxicity of Tumor Necrosis Factor-α in Galactosamine-Sensitized Mice

M. Yasuda, J. Nagakawa, I. Hishinuma, 1991 .

Protective effects of E3330, a novel quinone derivative, on galactosamine/tumor necrosis factor-alpha-induced hepatitis in mice.

J. Nagakawa, I. Hishinuma, K. Hirota, 1992, European journal of pharmacology.

Comparative Study of the Antiviral Activity of Acyl Derivatives of 2,2′-Anhydro-1-β-d-Arabinofuranosylcytosine and Other Nucleosides Against Encephalitis in Mice

J. G. Moffatt, T. Yamanaka, K. Sato, 1977, Antimicrobial Agents and Chemotherapy.

Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.

J. Nagakawa, I. Hishinuma, K. Hirota, 1992, The Journal of pharmacology and experimental therapeutics.

Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats.

J. Nagakawa, I. Hishinuma, K. Hirota, 1993, The Journal of pharmacology and experimental therapeutics.

Interleukin-1 alpha enhances hepatotoxicity of tumor necrosis factor-alpha in galactosamine-sensitized mice.

M. Yasuda, J. Nagakawa, I. Hishinuma, 1991, Immunopharmacology and immunotoxicology.

Eicosanoid profile and evidence for endotoxin tolerance in chronic ethanol-fed rats.

A. Nanji, T. Yamanaka, P. Thomas, 1994, Life sciences.

Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2.

A. Nanji, T. Yamanaka, S. M. Sadrzadeh, 1993, The American journal of pathology.

Inhibition of brain glutamic decarboxylase by running fit-inducing substances.

T. Yamanaka, Y. Nishizawa, T. Kodama, 1959, The Journal of vitaminology.

Effects of geranylgeranylacetone on gastrointestinal secretion in rats.

T. Yamanaka, T. Igarashi, M. Fujimoto, 1982, European journal of pharmacology.